Special Feature 1 – The Mechanisms and Functions of Blood Alzheimer’s disease biomarkers that facilitate early diagnosis of dementia
2023 saw the first use in clinical practice of anti-amyloid drugs, which inhibit the worsening of Alzheimer's disease symptoms by acting on the substance that causes the disease. While the move was reported as offering a long-awaited ray of hope in regard to dementia, for which there is no effective cure, one has to consider the fact that these drugs are indicated solely for mild, early-stage Alzheimer's disease. Accordingly, scientists are making haste to develop biomarkers that will enable the disease to be diagnosed accurately at an early stage. In particular, hopes are high that an efficient, noninvasive, and cheap blood biomarker could be put to widespread use in routine medical checkups and the like.